Fushine Biotech has received regulatory approval in China for its mycoprotein sourced from the fungus Fusarium venenatum. The approval was granted by the China National Health Commission after a thorough application process, with technical support from CIRS Group. This milestone allows for the use of mycoprotein as a food ingredient in China, joining other markets such as the EU, the US, and Australia where it has already been approved.

Mycoprotein from Fusarium venenatum is known for its high protein and fiber content, as well as its sustainability compared to conventional agriculture. The ingredient, often used by brands like Quorn in meat alternatives, has the potential to become a widespread and innovative solution in addressing global food crises and climate change. Recent research into gene-editing technologies like CRISPR may further improve the properties of mycoprotein, making it an even more attractive dietary option in the food industry.